You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
8 October 2026 - European immunology company argenx SE (EBR & NASDAQ: ARGX) on Thursday reported positive top-line results from a Phase 2 study of FB102, a first-in-class CD122 inhibitor, in adults with coeliac disease.FB102 achieved a statistica...
8 October 2026 - Clinical-stage biopharmaceutical company Vir Biotechnology Inc (Nasdaq:VIR) announced on Thursday that the US Food and Drug Administration (FDA) has granted Fast Track designation to VIR-5500, a PSMA-targeted PRO-XTEN dual-masked T-c...
8 October 2026 - German pharmaceutical and life sciences company Bayer AG (ETR:BAYN) (OTC:BAYRY) said on Thursday that the US Food and Drug Administration (FDA) has accepted its supplemental New Drug Application for KERENDIA (finerenone) for adults w...
8 October 2026 - Pharmaceutical company Boehringer Ingelheim announced on Wednesday the availability of the new Quarterable Snap-Tab design for PREVICOX (firocoxib) Chewable Tablets for dogs, following approval from the US Food and Drug Administratio...
8 October 2026 - Medical technology company Okami Medical announced on Wednesday that it has received approval from the US FDA for an expanded indication of its LOBO Vascular Occlusion System.The expanded indication extends the use of LOBO into perip...
7 October 2026 - Swiss healthcare company Roche (SIX: RO, ROP; OTCQX: RHHBY) announced on Wednesday that it has supplied two molecular testing instruments to the Institut National de Santé Publique (INSP) to expand Ebola testing capacity in th...
6 October 2026 - Defence and space technology company Voyager Technologies (NYSE:VOYG) said on Tuesday that it has signed a contract with the Center for the Advancement of Science in Space to manage Symphony Biosciences' cancer research experime...